Misplaced Pages

Almagate: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 20:27, 6 August 2011 editCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (no changed fields - added verified revid - updated 'DrugBank_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report [[Misplaced Pages talk:WikiProject_P← Previous edit Revision as of 15:44, 3 September 2011 edit undoBogBot (talk | contribs)Bots53,132 edits populated new fields in {{drugbox}} and reordered per bot approval. Report errors and suggestions to User_talk:BogBotNext edit →
Line 1: Line 1:
{{drugbox {{Drugbox
⚫ | verifiedrevid = 437148482
⚫ | IUPAC_name =
⚫ | image = <!--Almagate.svg-->

<!--Clinical data-->
| tradename =
| Drugs.com = {{drugs.com|international|almagate}}
⚫ | pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
⚫ | pregnancy_US = <!-- A / B / C / D / X -->
⚫ | pregnancy_category =
⚫ | legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
⚫ | legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
⚫ | legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
⚫ | legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
⚫ | legal_status =
⚫ | routes_of_administration = Oral

<!--Pharmacokinetic data-->
⚫ | bioavailability =
⚫ | protein_bound =
⚫ | metabolism =
⚫ | elimination_half-life =
⚫ | excretion =

<!--Identifiers-->
⚫ | CAS_number = 66827-12-1
⚫ | ATC_prefix = A02
⚫ | ATC_suffix = AD03
⚫ | PubChem = 71749
⚫ | DrugBank_Ref = {{drugbankcite|correct|drugbank}}
⚫ | DrugBank =
⚫ | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
⚫ | ChemSpiderID = 64792
| UNII_Ref = {{fdacite|correct|FDA}} | UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 568Z59H7ZJ | UNII = 568Z59H7ZJ
⚫ | KEGG_Ref = {{keggcite|correct|kegg}}
⚫ | verifiedrevid = 437148482
⚫ | KEGG = D02821
⚫ | IUPAC_name =

⚫ | image = <!--Almagate.svg-->
<!--Chemical data-->
⚫ | InChI = 1/CH2O3.Al.3Mg.9H2O/c2-1(3)4;;;;;;;;;;;;;/h(H2,2,3,4);;;;;9*1H2/q;+3;3*+2;;;;;;;;;/p-9
⚫ | chemical_formula = Al<sub>2</sub>Mg<sub>6</sub>(OH)<sub>14</sub>(CO<sub>3</sub>)<sub>2</sub> · 4 H<sub>2</sub>O

⚫ | molecular_weight = 314.99 g/mol
| smiles = .......C()=O.....O.O | smiles = .......C()=O.....O.O
⚫ | InChI = 1/CH2O3.Al.3Mg.9H2O/c2-1(3)4;;;;;;;;;;;;;/h(H2,2,3,4);;;;;9*1H2/q;+3;3*+2;;;;;;;;;/p-9
| InChIKey = MTEOMEWVDVPTNN-MBBIINEJAH | InChIKey = MTEOMEWVDVPTNN-MBBIINEJAH
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} | StdInChI_Ref = {{stdinchicite|correct|chemspider}}
Line 12: Line 49:
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = MTEOMEWVDVPTNN-UHFFFAOYSA-E | StdInChIKey = MTEOMEWVDVPTNN-UHFFFAOYSA-E
⚫ | CAS_number = 66827-12-1
⚫ | ATC_prefix = A02
⚫ | ATC_suffix = AD03
⚫ | PubChem = 71749
⚫ | DrugBank_Ref = {{drugbankcite|correct|drugbank}}
⚫ | DrugBank =
⚫ | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
⚫ | ChemSpiderID = 64792
⚫ | KEGG_Ref = {{keggcite|correct|kegg}}
⚫ | KEGG = D02821
⚫ | chemical_formula = Al<sub>2</sub>Mg<sub>6</sub>(OH)<sub>14</sub>(CO<sub>3</sub>)<sub>2</sub> · 4 H<sub>2</sub>O
⚫ | molecular_weight = 314.99 g/mol
⚫ | bioavailability =
⚫ | protein_bound =
⚫ | metabolism =
⚫ | elimination_half-life =
⚫ | excretion =
⚫ | pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
⚫ | pregnancy_US = <!-- A / B / C / D / X -->
⚫ | pregnancy_category=
⚫ | legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
⚫ | legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
⚫ | legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
⚫ | legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
⚫ | legal_status =
⚫ | routes_of_administration = Oral
}} }}
'''Almagate''' (trade name '''Almax''') is an ]- and ]-containing ]. It was first described in 1984.<ref>{{cite pmid|6548918}}</ref><ref>{{cite pmid|6439224}}</ref> '''Almagate''' (trade name '''Almax''') is an ]- and ]-containing ]. It was first described in 1984.<ref>{{cite pmid|6548918}}</ref><ref>{{cite pmid|6439224}}</ref>

Revision as of 15:44, 3 September 2011

Pharmaceutical compound
Almagate
Clinical data
AHFS/Drugs.comInternational Drug Names
Routes of
administration		Oral
ATC code
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
CompTox Dashboard (EPA)
Chemical and physical data
FormulaAl2Mg6(OH)14(CO3)2 · 4 H2O
Molar mass314.99 g/mol
3D model (JSmol)
SMILES
  • .......C()=O.....O.O
InChI
  • InChI=1S/CH2O3.Al.3Mg.9H2O/c2-1(3)4;;;;;;;;;;;;;/h(H2,2,3,4);;;;;9*1H2/q;+3;3*+2;;;;;;;;;/p-9
  • Key:MTEOMEWVDVPTNN-UHFFFAOYSA-E
  (verify)

Almagate (trade name Almax) is an aluminium- and magnesium-containing antacid. It was first described in 1984.

Adverse effects

Almagate is well tolerated. In a clinical trial, the most common adverse effects were diarrhea and nausea.

References

  1. Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 6548918, please use {{cite journal}} with |pmid=6548918 instead.
  2. Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 6439224, please use {{cite journal}} with |pmid=6439224 instead.
  3. Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 6548926, please use {{cite journal}} with |pmid=6548926 instead.
Drugs for acid related disorders: Antacids (A02A)
Magnesium (increases motility)
Aluminium (decreases motility)
Calcium
Sodium
Combinations and complexes
of aluminium, calcium and magnesium


Stub icon

This drug article relating to the gastrointestinal system is a stub. You can help Misplaced Pages by expanding it.

Categories: